Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
Pharmafocus.comNews Headlines Register for News Alert
News for August 2006
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Battle for Herceptin finally over
NICE gives go-ahead for drug's use in all HER2 positive women..(more)

 MabThera shows promise in multiple sclerosis
Hopes that drug's effectiveness may expand to other autoimmune diseases..(more)

 Business Intelligence Awards launched
New BOBIs will recognise the best in the pharma industry..(more)

 New broom Kindler sweeps away Pfizer bureaucracy
New chief executive hints that major company shake-up is ahead..(more)

 Pfizer switches agencies in time for Sutent's UK launch
Reynolds-Mackenzie to lead healthcare professional education drive..(more)

 Vernalis takes diabetes pain drug into phase II
V3381 should add to company's financial bounce-back..(more)

 NICE gives breast cancer drugs the green light
Decision will boost AIs to gold-standard treatment status..(more)

 Empowering patients will cut medication errors, says watchdog
Medicines management to form part of hospitals' ratings..(more)

 NHS research could face £300 million pound cut warns BMA
Cooksey Review recommends creation of single R&D NHS fund..(more)

 Huge regional variations in NHS spending revealed
Transparency of DoH budget data could make NHS give better value for money ..(more)

 Generic version of Plavix launched in US
But battle lines are drawn in patent fight..(more)

 GSK delivers strong quarterly performance
10% rise in sales earns company five billion pounds..(more)

 Lilly's new products drive up sales
Cut-backs and improved sales figures help Lilly bounce back ..(more)

 Takeda selects London for new European business
Further boost for UK as favoured location for pharma companies..(more)

 Crestor leads AZ European sales growth
Company says it's on target to reach 2006 financial goals..(more)

 Pfizer's smoking-cessation drug a step closer to European approval
Trial results point to potential blockbuster status for Champix..(more)

 McKinnell makes early exit from Pfizer
His replacement, Kindler, faces a tough initiation period..(more)

 Pfizer's Sutent receives conditional EMEA approval
Drug's sales expected to equal that of its nearest rival, Nexavar..(more)

 Tighter safeguards proposed for high-risk clinical trials
Report says Northwick Park test was at fault for not predicting safe dose..(more)

 Aurora to raise European allergy awareness for UCB Pharma
Agency plans tailor-made Xyzal campaign for each country..(more)

 Significant reduction in animal extremist attacks
ABPI says new figures mark a sea-change..(more)

 NICE Herceptin appeal decision expected in weeks
PCT seeks clarification on which women can receive drug and for how long..(more)

 NICE boost for Taxotere
Approval increases chemotherapy choices for early breast cancer patients..(more)

 Nexavar gets EU go-ahead in advanced kidney cancer
Drug represents first treatment breakthrough for 10 years..(more)

 Wyeth looks for European boost from Enbrel NICE guidance
Drug gets go-ahead to be last line psoriasis treatment ..(more)

 New NHS Chief Executive appointed
NHS man David Nicholson beats off international and private sector competition..(more)

 New organisation to advise on patients' medicines leaflet
Patient groups to be asked to comment on clarity of information..(more)

 First cervical cancer vaccine close to European approval
100% success rate for Gardasil in phase III trials..(more)

 MDS named top clinical research company in Europe
CRO rated as 'excellent' by respondents in CenterWatch survey ..(more)

 Study boost for AstraZeneca's Nexium
Drug found to be more effective than UK market leader Zoton..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.